{
  "paper_metadata": {
    "pmid": "32000831",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the Glu54Gln mutation in the TTR gene associated with hereditary transthyretin amyloidosis (ATTRh) in Romanian patients, detailing penetrance data and clinical characteristics."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.162G>A",
      "protein_notation": "p.Glu54Gln",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 18,
        "demographics": "10 females, 8 males; age range: 16-53 years; Romanian ethnic group",
        "phenotype": "Hereditary transthyretin amyloidosis (ATTRh) with neurological and cardiac involvement"
      },
      "penetrance_data": {
        "total_carriers_observed": 18,
        "affected_count": 10,
        "unaffected_count": 5,
        "uncertain_count": 3,
        "penetrance_percentage": 55.56,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "1",
          "age_at_evaluation": 48,
          "age_at_onset": 36,
          "age_at_diagnosis": 48,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Paresthesia, heart failure, dysphagia, diarrhea",
          "evidence_sentence": "Patient 1 [A] age at diagnosis 48, symptoms at onset: Paresthesia, heart failure, dysphagia, diarrhea."
        },
        {
          "individual_id": "2",
          "age_at_evaluation": 43,
          "age_at_onset": 36,
          "age_at_diagnosis": 43,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Cardiac symptoms, heart failure",
          "evidence_sentence": "Patient 2 [B] age at diagnosis 43, symptoms at onset: Cardiac symptoms, heart failure."
        },
        {
          "individual_id": "3",
          "age_at_evaluation": 35,
          "age_at_onset": 11,
          "age_at_diagnosis": 35,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Weight loss, heart failure, paresthesia",
          "evidence_sentence": "Patient 3 [C1*] age at diagnosis 35, symptoms at onset: Weight loss, heart failure, paresthesia."
        },
        {
          "individual_id": "4",
          "age_at_evaluation": 49,
          "age_at_onset": 24,
          "age_at_diagnosis": 49,
          "sex": "female",
          "affected_status": "alive",
          "phenotype_details": "Paresthesia, weight loss, heart failure",
          "evidence_sentence": "Patient 4 (C2*) age at diagnosis 49, symptoms at onset: Paresthesia, weight loss, heart failure."
        },
        {
          "individual_id": "5",
          "age_at_evaluation": 51,
          "age_at_onset": 48,
          "age_at_diagnosis": 51,
          "sex": "male",
          "affected_status": "alive",
          "phenotype_details": "Diarrhea, weight loss",
          "evidence_sentence": "Patient 5 [D] age at diagnosis 51, symptoms at onset: Diarrhea, weight loss."
        },
        {
          "individual_id": "6",
          "age_at_evaluation": 52,
          "age_at_onset": 9,
          "age_at_diagnosis": 52,
          "sex": "male",
          "affected_status": "alive",
          "phenotype_details": "Paresthesia, weight loss",
          "evidence_sentence": "Patient 6 [E1*] age at diagnosis 52, symptoms at onset: Paresthesia, weight loss."
        },
        {
          "individual_id": "7",
          "age_at_evaluation": 47,
          "age_at_onset": 24,
          "age_at_diagnosis": 47,
          "sex": "female",
          "affected_status": "alive",
          "phenotype_details": "Paresthesia, weight loss",
          "evidence_sentence": "Patient 7 [E2*] age at diagnosis 47, symptoms at onset: Paresthesia, weight loss."
        },
        {
          "individual_id": "8",
          "age_at_evaluation": 47,
          "age_at_onset": 7,
          "age_at_diagnosis": 47,
          "sex": "female",
          "affected_status": "alive",
          "phenotype_details": "Paresthesia",
          "evidence_sentence": "Patient 8 [E3**] age at diagnosis 47, symptoms at onset: Paresthesia."
        },
        {
          "individual_id": "9",
          "age_at_evaluation": 49,
          "age_at_onset": 36,
          "age_at_diagnosis": 49,
          "sex": "female",
          "affected_status": "alive",
          "phenotype_details": "Paresthesia, heart failure",
          "evidence_sentence": "Patient 9 [F] age at diagnosis 49, symptoms at onset: Paresthesia, heart failure."
        },
        {
          "individual_id": "10",
          "age_at_evaluation": 49,
          "age_at_onset": 60,
          "age_at_diagnosis": 49,
          "sex": "female",
          "affected_status": "alive",
          "phenotype_details": "Paresthesia, heart failure",
          "evidence_sentence": "Patient 10 [G] age at diagnosis 49, symptoms at onset: Paresthesia, heart failure."
        },
        {
          "individual_id": "11",
          "age_at_evaluation": 42,
          "age_at_onset": 6,
          "age_at_diagnosis": 42,
          "sex": "female",
          "affected_status": "alive",
          "phenotype_details": "Weight loss, gastroparesis",
          "evidence_sentence": "Patient 11 [H] age at diagnosis 42, symptoms at onset: Weight loss, gastroparesis."
        },
        {
          "individual_id": "12",
          "age_at_evaluation": 41,
          "age_at_onset": 48,
          "age_at_diagnosis": 41,
          "sex": "female",
          "affected_status": "alive",
          "phenotype_details": "Paresthesia, weight loss",
          "evidence_sentence": "Patient 12 [I1*] age at diagnosis 41, symptoms at onset: Paresthesia, weight loss."
        },
        {
          "individual_id": "13",
          "age_at_evaluation": 46,
          "age_at_onset": 60,
          "age_at_diagnosis": 46,
          "sex": "female",
          "affected_status": "alive",
          "phenotype_details": "Paresthesia, weight loss",
          "evidence_sentence": "Patient 13 [I2*] age at diagnosis 46, symptoms at onset: Paresthesia, weight loss."
        }
      ],
      "functional_data": {
        "summary": "The Glu54Gln mutation in TTR is associated with destabilization and aggregation of TTR protein, leading to amyloid fibril formation.",
        "assays": []
      },
      "segregation_data": "The Glu54Gln variant segregates with disease in families, as indicated by family history of neurological involvement or death at a young age.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This is the first report of the Glu54Gln mutation in the Romanian population.",
      "key_quotes": [
        "This is the largest Glu54Gln-mutated ATTRh cohort diagnosed to date, and to our knowledge the first describing this variant worldwide.",
        "All symptomatic patients had a family history of neurological involvement or death at a young age."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Characteristics of symptomatic ATTR patients with the Glu54Gln mutation",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR gene variant were extracted successfully."
  }
}